Comparing overdose mortality associated with methadone and buprenorphine treatment

Drug and Alcohol Dependence

Volumn 104, Issue 1-2, 2009, Pages 73-77

  Bell, James R ^a   Butler, Bethany ^b   Lawrance, Anne ^c   Batey, Robert ^c   Salmelainen, Pia ^d  

^a Langton Centre   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c New South Wales Government   (Australia)

^d Pharmaceutical Services Branch   (Australia)

Author keywords

Buprenorphine; Heroin; Methadone; Mortality; Overdose

Indexed keywords

BUPRENORPHINE; METHADONE;

ARTICLE; AUTOPSY; CAUSE OF DEATH; CONTROLLED STUDY; HUMAN; INTOXICATION; METHADONE TREATMENT; MORTALITY; OPIATE ADDICTION; PRIORITY JOURNAL; SUDDEN DEATH;

ADULT; BUPRENORPHINE; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; NEW SOUTH WALES; OPIOID-RELATED DISORDERS; OVERDOSE; RISK ASSESSMENT;

EID: 67651122922     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.03.020     Document Type: Article

References (16)

1. Auriacombe M., Franques P., and Tignol J. Deaths attributable to methadone vs buprenorphine in France. Journal of the American Medical Association 285 (2001) 45
2. Bargagli A.M., Hickman M., Davoli M., et al. Drug related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health 16 2 (2008) 198-202
3. Buster M.C., van Brussel G.H., and van den Brink W. An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam. Addiction 97 8 (2002) 993-1001
4. Clausen T., Anchersen K., and Waal H. Mortality prior to, during and after opiopid maintenance treatment (OMT); a national, prospective cross-registry study. Drug and Alcohol Dependence 94 (2008) 151-157
5. In: Darke S., Degenhardt L., and Mattick R.P. (Eds). Mortality Amongst Illicit Drug Users (2006), Cambridge University Press, Cambridge
6. Davoli M., et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction 102 (2007) 1954-1959
7. Fugelstad A., Stenbacka M., Liefman A., Nylander M., and Thiblin I. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction 102 (2007) 406-412
8. Gibson A., and Degenhardt L. Mortality related to pharmacotherapies for opioid dependence; a comparative analysis of coronial records. D&A Review 26 (2007) 405-410
9. Heinemann A., Iwersen-Bergmann S., Stein S., Schmoldt A., and Puschel K. Methadone-related fatalities in Hamburg 1990-1999: implications for quality standards in maintenance treatment?. Forensic Science International 113 (2000) 449-455
10. Iversen J., and Maher L. Drug injection trends among participants in the Australian Needle and Syringe Program Survey 2003-2007. IDRS Drug Trends Bulletin, October 2008 (2008), National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney
11. Jaffe J., and O'Keeffe C. From morphine clinics to buprenorphine; regulating opioid agonist treatment of addiction in the United States. Drug and Alcohol Dependence 70 (2003) S3-S11
12. Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Science International 121 (2001) 65-69
13. O'Brien, S., Black, E., Roxburgh, A., Degenhardt, L., Bruno, R., Campbell, G., et al., 2007. Australian drug trends 2006: findings from the illicit drug reporting system (IDRS). NDARC Monograph 60. National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
14. Sunjic S., and Zador D. Methadone syrup-related deaths in New South Wales, Australia, 1990-95. Drug and Alcohol Review 18 (1999) 409-415
15. Walsh S.L., and Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug and Alcohol Dependence 70 (2003) S13-S27
16. Zanis D.A., and Woody G.E. One-year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence 52 (1998) 257-260